Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Nat Brinn
AddedFeb 17, 2024
UpdatedMay 31, 2026
Nat Brinn

Nat Brinn

Board Member, NovaTract Surgical

Crunchbase

Nat Brinn's Career

NovaTract Surgical
NovaTract Surgical

Madison, CT, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Nat Brinn's Career

NovaTract Surgical
NovaTract Surgical
Series A$4.7M82010Madison, CT, US
Board Member· Board

Leadership at NovaTract Surgical

Jonathan SackierJonathan SackierBoard Member
Eleanor TandlerEleanor TandlerBoard Member
Mary PolanMary PolanBoard Member
Peter LongoPeter LongoBoard Member

Similar to NovaTract Surgical

Minimally Invasive DevicesMinimally Invasive DevicesColumbus, OH, USSurgical Devicesest. 2009Minimally Invasive DevicesColumbus, OH, US · est. 2009

Developing surgical tools for enhanced visualization in minimally invasive surgeries across the US.

Public · $47.1M33
Trocar SweepTrocar SweepDallas, TX, USMedical Devicesest. 2011Trocar SweepDallas, TX, US · est. 2011

Trocar Sweep: Innovating laparoscopic surgery with proprietary devices for enhanced visualization, founded in 2011.

Angel · $500k375
LapovationsLapovationsFayetteville, AR, USMedical Devicesest. 2016LapovationsFayetteville, AR, US · est. 2016

Lapovations: Innovating laparoscopy with minimally invasive, simplified medical devices.

Pre-Seed · $3.2M7
SanovasSanovasSan Rafael, CA, USSurgical Toolsest. 2009SanovasSan Rafael, CA, US · est. 2009

Sanovas, Inc. develops and offers minimally invasive surgical tools for complex medical procedures in the US.

Angel · $9.2M39

Nat Brinn's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Nat Brinn

Bill FrankBill FrankBoard Member · AzotiBrad CoronaBrad CoronaFounder · Jack RobieStuart NagaeStuart NagaeBoard Member · CivicEyeJames HardimanJames HardimanBoard Member · Sequence BioKevin ChengKevin ChengBoard Member · OssioScott NolanScott NolanPartner · Founders Fund